Domingo Francisco Javier
Díez Martínez
Investigador hasta 2021
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (11)
2023
-
Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials
International Journal of Cardiology, Vol. 377, pp. 86-88
2020
-
Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
Open Heart, Vol. 7, Núm. 1
2017
-
Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
Open Heart, Vol. 4, Núm. 2
2015
-
Diltiazem treatment for pre-Clinical hypertrophic cardiomyopathy sarcomereMutation carriers: A pilot randomized trial to modify disease expression
JACC: Heart Failure, Vol. 3, Núm. 2, pp. 180-188
2013
-
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
Circulation: Cardiovascular Imaging, Vol. 6, Núm. 3, pp. 415-422
2011
2010
-
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
New England Journal of Medicine, Vol. 363, Núm. 6, pp. 552-563
-
The authors reply
New England Journal of Medicine
2006
-
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: Implications for clinical and subclinical atherosclerosis
Journal of the American College of Cardiology, Vol. 47, Núm. 7, pp. 1369-1378
2002
-
Pathophysiologic and therapeutic importance of tissue ACE: A consensus report
Cardiovascular Drugs and Therapy, Vol. 16, Núm. 2, pp. 149-160
2001
-
The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data
American Journal of Cardiology, Vol. 88, Núm. 9 SUPPL. 1, pp. 1-20